Handling Human Samples Is Worth the Risk

Brad FitzpatrickJust recently, our university's Biosafety Committee told the faculty that we must discontinue certain laboratory exercises. The long list includes human blood, blood products, body fluids (cerebrospinal, synovial, pleural, pericardial, peritoneal, and amniotic fluids, saliva, and urine), contaminated needles, pathological wastes, microbiological wastes, and unfixed human tissues and organs.We think that this decision, based on safety reasons that we can appreciate, is wrong. To q

Written byGilbert Ellis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Brad Fitzpatrick

Just recently, our university's Biosafety Committee told the faculty that we must discontinue certain laboratory exercises. The long list includes human blood, blood products, body fluids (cerebrospinal, synovial, pleural, pericardial, peritoneal, and amniotic fluids, saliva, and urine), contaminated needles, pathological wastes, microbiological wastes, and unfixed human tissues and organs.

We think that this decision, based on safety reasons that we can appreciate, is wrong. To quote our previously published article: "We feel human body fluids cannot be replaced in the teaching of physiology and can still be used effectively with minimal exposure risks if simple precautions are followed."1

The Ellis and Sanborn labs have been using body fluids in teaching biology and physiology since 1970 and 1984, respectively, and to our knowledge, we have never compromised a student, or anyone else, by using authentic blood, urine, or saliva. We understand the issues and we always err on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies